prostate cancer
| 2 min read
The newly discovered cells protect the tumor by recruiting regulatory T cells to create an immunosuppressive environment.
| 4 min read
Data on a new oral pill for Duchenne muscular dystrophy, a miss for a heart drug, a $10B acquisition of Crinetics, and more led the news this week.
| 4 min read
An executive order on drug manufacturing, a controversial HHS appointee, a diabetes drug for prostate cancers, and more were this week’s top industry headlines.
| 3 min read
An immune checkpoint inhibitor and chemotherapy extended progression-free survival in late-stage small cell bladder and prostate cancers.
| 3 min read
A new study suggests that an extra cup of joe may help people survive longer with prostate cancer if they are fast caffeine metabolizers.
| 3 min read
Researchers use machine learning to identify generic drugs that are promising candidates for affordable and accessible cancer treatments.
| 3 min read
APIS, University of Virginia hope to leverage HULLK lncRNA as a prostate cancer biomarker
Page 1 of 1 - 7 Total Items
